Breast Cancer-Targets and Therapy

Papers
(The median citation count of Breast Cancer-Targets and Therapy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
<p>Resistance and Overcoming Resistance in Breast Cancer</p>44
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer31
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action16
Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis15
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells14
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy13
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review13
<p>Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women</p>13
<p>Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives</p>12
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer11
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis11
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data9
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab9
<p>Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients</p>9
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up8
<p>Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data</p>8
<p>Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy</p>7
Systematic Review of Breast-Q: A Tool to Evaluate Post-Mastectomy Breast Reconstruction7
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib7
<p>Breast Cancer Detection Using Low-Frequency Bioimpedance Device</p>7
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review7
<p>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</p>7
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications6
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers6
<p>Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data</p>6
<p>Breast Self-Examination Practice Among Women in Jimma, Southwest Ethiopia: A Community-Based Cross-Sectional Study</p>6
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective6
<p>Knowledge and Practice of Breast Self-Examination Among Young Women in Tertiary Education in Addis Ababa, Ethiopia</p>5
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer5
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?5
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients5
An Update on the Molecular Pathology of Metaplastic Breast Cancer5
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival4
<p>A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma</p>4
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer4
<p>Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy</p>4
Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer4
Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions4
<p>Quality of Life Among Breast Cancer Patients Attending Hawassa University Comprehensive Specialized Hospital Cancer Treatment Center</p>4
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold4
Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better4
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer3
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia3
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer3
<p>Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer</p>3
Identifying Risk Factors of Breast Cancer Among Women Attending Selected Hospitals of Addis Ababa City: Hospital-Based Unmatched Case-Control Study3
<p>Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study</p>3
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells3
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer3
Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?3
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment3
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment3
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors3
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth3
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective3
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment3
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound3
<p>Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis</p>3
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia3
<p>Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility</p>3
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer3
Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis3
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series2
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States2
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?2
<p>Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial</p>2
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer2
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women2
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection2
Genetic Influences in Breast Cancer Drug Resistance2
Breast Cancer in Italy: Stage and Region Distribution2
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal2
Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications2
Effectiveness of Psycho-Education Intervention Programme on Coping Strategies Among Jordanian Women Diagnosed with Breast Cancer: A Randomised Controlled Trial2
<p>Outcomes of Sentinel Lymph Node Biopsy Using Blue Dye Method for Early Breast Cancer – A Single-Institution Experience in the Philippines</p>2
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy2
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer2
Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins2
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer2
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration2
An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC2
<p>Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer</p>2
<p>Do Men and Women in Saudi Arabia Have the Same Level of Awareness and Knowledge of Breast Cancer? A Cross-Sectional Study</p>2
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer2
Evaluation of Cytotoxicity of the Methanolic Extract of Red Sea Marine Sponge Xestospongia Testudinaria and Its Related Compounds Against MCF-7 Human Breast Cancer Cells1
Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer1
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers1
Pregnancy Associated Invasive Apocrine Carcinoma of the Breast: Case Report from Ethiopia1
In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach1
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models1
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay1
Occult Invasive Lobular Carcinoma Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical Resection: A Case Report and Review of Literature1
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer1
Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques1
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib1
Traditional Chinese Medicine for Breast Cancer: A Review1
The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study1
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk1
Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries1
Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study1
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients1
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics1
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review1
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”1
Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay1
Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer1
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study1
Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review1
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review1
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification1
Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study1
Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital1
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer1
Psychometric Properties and Factorial Analysis of the Arabic McGill-QoL Questionnaire in Breast Cancer1
Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis1
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer1
<p>Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam</p>1
Association of Endocrine Therapy and Dementia in Women with Breast Cancer1
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery1
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer1
The Involvement of Insulin-Like Growth Factor 2 Messenger Ribonucleic Acid-Binding Protein 2 in the Regulation of the Expression of Breast Cancer-Related Genes1
Detecting the Frequency of c.5946delT Pathogenic Variant in the BRCA2 Gene and Associated Risk Factors Among Breast Cancer Patients Visiting Felege Hiwot Referral Hospital and University of Gondar Com1
0.022487163543701